Literature DB >> 18473444

Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.

Gaixia Xu1, Ken-Tye Yong, Indrajit Roy, Supriya D Mahajan, Hong Ding, Stanley A Schwartz, Paras N Prasad.   

Abstract

We report here, what we believe to be the first time, the successful transport of bioconjugated quantum rods (QRs) across an in vitro blood-brain barrier (BBB) model via a receptor-mediated transport, as well as the use of QR multiplexing technique to compare simultaneously the transmigration efficiency of different biomolecules across the BBB. The migration rate of bioconjugated QRs crossing the in vitro BBB was found to be concentration- and time-dependent. This work illustrates a nanoparticle-based platform that will not only allow a direct visualization of the transmigration ability of various kinds of biomolecules across the BBB, but also facilitate the development of novel diagnostic and therapeutic nanoprobes for early diagnosis and therapy of various disorders of the brain following systemic administration.

Entities:  

Mesh:

Year:  2008        PMID: 18473444     DOI: 10.1021/bc700477u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  26 in total

1.  Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.

Authors:  Supriya D Mahajan; Indrajit Roy; Gaixia Xu; Ken-Tye Yong; Hong Ding; Ravikumar Aalinkeel; Jessica Reynolds; Donald Sykes; Bindukumar B Nair; Elaine Y Lin; Paras N Prasad; Stanley A Schwartz
Journal:  Curr HIV Res       Date:  2010-07       Impact factor: 1.581

2.  Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Authors:  Fang Wu; Sherry A Wuensch; Mitra Azadniv; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 3.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

Review 4.  Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.

Authors:  Luisa Fiandra; Amedeo Capetti; Luca Sorrentino; Fabio Corsi
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-10       Impact factor: 4.147

5.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 6.  Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.

Authors:  Hu Yang
Journal:  Pharm Res       Date:  2010-07-01       Impact factor: 4.200

7.  Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.

Authors:  Hong Ding; Vidya Sagar; Marisela Agudelo; Sudheesh Pilakka-Kanthikeel; Venkata Subba Rao Atluri; Andrea Raymond; Thangavel Samikkannu; Madhavan P Nair
Journal:  Nanotechnology       Date:  2014-01-09       Impact factor: 3.874

8.  Glycosylated quantum dots for the selective labelling of Kluyveromyces bulgaricus and Saccharomyces cerevisiae yeast strains.

Authors:  Joël Coulon; Ilan Thouvenin; Fadi Aldeek; Lavinia Balan; Raphaël Schneider
Journal:  J Fluoresc       Date:  2010-03       Impact factor: 2.217

9.  Fluorescent nanocrystals reveal regulated portals of entry into and between the cells of Hydra.

Authors:  Claudia Tortiglione; Alessandra Quarta; Maria Ada Malvindi; Angela Tino; Teresa Pellegrino
Journal:  PLoS One       Date:  2009-11-02       Impact factor: 3.240

10.  Real-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobes.

Authors:  Kiyotaka Tokuraku; Meg Marquardt; Tsuneya Ikezu
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.